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Abstract
Purpose Prevalence of depression is high in patients
with chronic kidney disease. Depression is associated
with increased mortality and the higher rate of suicides
in these patients. The aim of the study was to estimate
the prevalence of depressive symptoms in haemodi-
alyzed patients in Upper Silesia region of Poland and
the possible role of inflammation in depression
development.
Methods Six hundred and ninety-seven haemodia-
lyzed patients from 22 dialysis centres in Upper Silesia
region of Poland were enrolled into the study. Mean
age was 59.1 ± 0.5 years, and mean time of dialysis
treatment was 3.6 ± 0.2 years. Each patient received
21-item Beck Depression Inventory (BDI) question-
naire for depression screening. Additional questions
considering length of dialysis treatment, concomitant
diseases and number of days spent in hospitals during
the last year were also asked.
Results Depressive symptoms were found in 268
(38.6 %) patients. Patients with depressive symptoms
when compared with the patients without them tended
to have higher C-reactive protein plasma concentration
(14.3 ± 1.3 vs. 11.1 ± 0.9 mg/l; p = 0.067) and were
more often dialyzed with central catheter (27.6 vs.
18.2 %; p = 0.0042). During the last year, patients
with depressive symptoms spent in hospitals more days
than patients without depressive symptoms (24.3 vs.
15.3 days, respectively; p \ 0.0001). Significant posi-
tive correlation between BDI score and C-reactive
protein level (r = 0.1625; p = 0.001) was found both
in univariate and multivariate analysis.
Conclusions (1) Depressive symptoms are fre-
quently found (38.6 %) in haemodialyzed patients in
Upper Silesia part of Poland. (2) Catheter placement
and inflammation seem to play an important role in the
pathogenesis of depression in haemodialysis patients.
Keywords Chronic kidney disease  Haemodialysis 
Depression  Inflammation
Introduction
Depression issue in haemodialyzed patients has been
addressed many times in the past, and by now, we may
expect about 3,000 haemodialyzed patients diagnosed
for depression described in the literature through the
last 30 years. During this time, a rapid and pronounce
development in renal replacement therapy was
observed which was followed by deep change in
profile of haemodialyzed population. However,
depression rate in chronic kidney disease (CKD)
patients does not differ from general population [1],
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and reported prevalence of depression in ESRD
patients is much higher than in general population
[2], did not change over time [3–9] and is the most
common psychiatric disorder in this group of patients
[10]. The diagnosis of depression still remains chal-
lenging which was shown by Donna Grant in 2008 on
British population of haemodialyzed patients [11].
Depression negatively influences compliance with
medical treatment and dietary adherence in different
groups of chronically ill patients, including patients
with CKD and ESRD [12–14]. That in turn can be
associated with poor outcomes in CKD patients
independently of other clinical factors like CKD
stage, serum albumin, haemoglobin blood or phos-
phorus plasma concentrations and comorbidities [15,
16]. It was proven that depression influences the
lifetime of patients with CKD [17–19] and may affect
suicide rate in this population [20].
Etiopathology of depression in patients with CKD
is multifactorial, both medically and psychologically
based. Theory of major loses explains both back-
grounds for depression development. Sense of loss
accompanies patients from very early stages of CKD
to the most profound loss in ESRD. Additional factors
also influence development of depression in ESRD
patients. Chronic pain and sleep disturbances affect
health-related quality of life (HRQOL) and depression
in patients with all stages of CKD [21] and with ESRD
[22–24], with regard to not clear causality and order.
Additionally, numerous authors underline role of
patient’s inflammatory status in depression develop-
ment [25–28].
Since there is little data about prevalence of
depression in haemodialyzed population in Poland,
we designed a study on large group of haemodialyzed
patients to address this issue. We also wanted to
identify potential risk factors for depression develop-
ment in this population with regard to inflammatory
status. The question arises: is depression a new player
in MIA syndrome? Confirming this hypothesis
may result in changing MIA to MIAD syndrome
abbreviation (malnutrition–inflammation–atheroscle-
rosis–depression) in the future.
Materials and methods
Six hundred and ninety-four haemodialyzed patients
from 22 dialysis centres in Upper Silesia region of
Poland were enrolled into the study. Patients’ charac-
teristics were shown in Tables 1 and 2. Each patient
received questionnaire consisting of the parts: Beck
Depression Inventory (BDI) test, social data and
medical history data.
Presence of depressive symptoms was measured
with BDI [29] that is a well-validated measure of
depression in patients with ESRD [4]. The BDI is a
21-item, patient self-rated scale that has been used in
Table 1 Characteristics—clinical data of dialyzed patients
with chronic kidney disease
Number of patients 694
Gender
Male 387 (55.7 %)
Female 307 (44.3 %)
Age (years) 59.1 ± 0.5
Weight (kg) 71.2 ± 0.6
Height (cm) 166.5 ± 0.4
Haemodialysis time per week (h) 12.5 ± 0.2
Haemodialysis time (years) 3.6 ± 0.2
Vascular access
Venous catheter 159 (24.2 %)
Arterio-venous fistula 535 (75.8 %)
Dialysis centre
Non-profit 434 (63.4 %)
Commercial 260 (36.6 %)
Cause of CKDa
Diabetes mellitus 148 (21.2 %)
Hypertension 284 (40.7 %)
Glomerulonephritis 122 (17.5 %)
Other 96 (13.8 %)
Other diseasesa
Chronic pulmonary obstructive disease 17 (2.4 %)
Coronary artery disease 166 (23.8 %)
History of myocardial infarction 83 (11.9 %)
History of stroke 43 (6.2 %)
Glaucoma 45 (6.5 %)
Hearing problems 109 (15.6 %)
Laboratory results
Haemoglobin (g/dl) 11.0 ± 0.1
Phosphate (mmol/l) 1.8 ± 0.1
Protein (g/l) 67.7 ± 0.3
Cholesterol (mmol/l) 4.7 ± 0.1
C-reactive protein (mg/l) 11.7 ± 0.7
Mean values ± SEM
a Self reported by patients
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haemodialyzed patients and correlates highly with
diagnostic criteria for depression, quality of life,
functional status, severity of illness and mortality
over time [30, 31]. The BDI test uses 0–3 Likert scales,
with total scores ranging from 0 to 63. Higher scores
correlate with more severe depression. BDI score[16
is characteristic for presence of moderate to severe
depressive symptoms.
Social part of questionnaire considered marriage
status, education and living conditions.
Medical history considered: primary illness as
cause of CKD, additional illnesses, length of dialysis
treatment, ownership type of dialysis centre (non-
profit or commercial), type of vascular access, number
of days spent in hospitals during the last year and
number of pills taken daily.
In each patient, the following laboratory results
were obtained: blood haemoglobin concentration,
serum protein, cholesterol and C-reactive protein
concentrations. For these data collections, question-
naires were temporarily unblinded locally in dialysis
centres.
Age, weight, height and gender of each patient were
also obtained.
Participation in this study was voluntary and
anonymous although good understanding of given
questions was obligatory. Only complete question-
naires were investigated.
Statistical analysis was made with Statistica 5.0 PL
program. Data were presented as means and standard
error of means (SEM). Differences between groups
were calculated with T Student and v2 tests. Correla-
tion analysis was performed with Pearson’s test and
multiple regression test.
Results
Overall BDI score for studied population was
14.7 ± 0.4 points. Moderate to severe depressive
symptoms of depression (BDI [ 16) were found in
268 (38.6 %) patients of studied population. Detailed
comparison between groups with or without depres-
sion is shown in Table 3a, b.
If compared with patients without depressive
symptoms, patients with depressive symptoms were
older (61.7 ± 14.2 vs. 57.5 ± 14.4 years, respec-
tively; p \ 0.001), spent more days in hospitals during
the last year (24.3 vs. 15.3 days, respectively;
p \ 0.001) and tended to have higher C-reactive
protein plasma concentration (14.3 ± 1.3 vs.
11.1 ± 0.9 mg/l, respectively; p = 0.067). Amongst
patients with depressive symptoms there were more
dialyzed ones with central catheter than in group
without depressive symptoms (28 vs. 19 %, respec-
tively; p = 0.004) and more patients were treated by
non-profit dialysis centres (70 vs. 59 %, respectively;
p = 0,003). Patients dialyzed in non-profit dialysis
centres spent more days in hospital during the last year
than patients dialyzed in commercial ones (21.6 vs.
13.8 days, respectively; p \ 0.001).
In group with depressive symptoms there were
more widowed patients than in group without depres-
sive symptoms (24 vs. 13 %, respectively). Consider-
ing all investigated population, widowed patients had
higher BDI score than married and lonely patients
(17.7 vs. 14.3 points, respectively; p \ 0.001 and vs.
13.0 points; p \ 0.001, respectively). Married and
lonely patients were not different with regard to BDI
score (14.3 vs. 13.0 points, respectively; p = 0.162).
There were also differences in education level—in
the group with depressive symptoms there were 44/50/
6 % of patients after elementary, high schools and
college comparing to 37/52/11 % in the group with-
out depressive symptoms, respectively (p = 0.027).
Considering all investigated population, patients
after college had significantly lower BDI score than
Table 2 Characteristics—social and other data of dialyzed
patients with chronic kidney disease
Marriage status
Married 434 (62.3 %)
Alone 126 (18.1 %)
Widowed 127 (18.2 %)
Living conditions
With family 585 (83.9 %)
Alone 98 (14.1 %)
Education
Elementary 270 (38.7 %)
High school 349 (50.1 %)
College 66 (9.5 %)
Number of pills taken daily 10.7 ± 0.2
Number of days spent in hospital
during the last year
18.7 ± 0.9
BDI score 14.7 ± 0.4
Mean values ± SEM
BDI beck depression inventory
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patients after elementary school—12.7 vs. 15.7 points
(p = 0.029).
There were no significant differences between
groups with regard to gender and family status (living
alone or with family).
If compared with patients with arterio-venous
fistula, the group of patients dialyzed with central
venous catheter were characterized by significantly
higher C-reactive protein serum concentration (15.9
vs. 11.0 mg/l; p = 0.013) and BDI score (16.7 vs. 14.0
points; p = 0.002) (Table 4). This group was charac-
terized also by more days spent in hospital during the
last year (28.9 vs. 15.6; p \ 0,001) and shorter dialysis
treatment time (2.9 vs. 3.8 years; p = 0.025).
Significant positive correlations between BDI score
and age (r = 0.152; p = 0.002), days spent in hospi-
tals during the last year (r = 0.210; p \ 0.001) and
C-reactive protein level (r = 0.162; p = 0.001) were
found in entire studied population. Also multivariate
regression analysis was performed with BDI score as
dependent variable and independent variables: gender,
age, time spent on dialysis treatment, type of vascular
access, type of dialysis unit, marriage status, living
conditions, educational level, number of pills taken
daily, days spent in hospitals during the last year,
blood concentrations of haemoglobin, plasma concen-
tration of phosphate, cholesterol, protein and CRP.
The multivariate regression analysis showed that BDI
score depends on age (p = 0.019; beta = 0.117), days
spent in hospitals during the last year (p = 0.004;
beta = 0.141) and C-reactive plasma concentration
(p = 0.037; beta = 0.099).
Table 3 Characteristics and comparison between groups of









Number of patients 268 (38.6 %) 426 (61.4 %)
BDI score 24.8 5.4
Age (years) 61.8 ± 0.8 57.5 ± 0.7 0.002
Weight (kg) 71.7 ± 0.9 70.8 ± 0.7 0.438
Gender
Male 141 (52.6 %) 246 (57.6 %) 0.185*
Female 127 (47.4 %) 180 (42.4 %)
Haemodialysis time
per week (h)
12.8 ± 0.4 12.6 ± 0.2 0.227
Haemodialysis
time (years)
3.5 ± 0.3 3.7 ± 0.2 0.616
Vascular access
Venous catheter 77 (27.6 %) 82 (18.2 %) 0.004*
Arterio-venous fistula 191 (72.4 %) 344 (80.8 %)
Dialysis centre
Non-profit 186 (70.2 %) 248 (58.8 %) 0.003*
Commercial 82 (29.8 %) 178 (41.2 %)
Cause of CKDa
Diabetes mellitus 67 (24.6 %) 81 (19.1 %) 0.060*
Hypertension 121 (44.5 %) 163 (38.4 %) 0.072*
Glomerulonephritis 40 (14.7 %) 82 (19.3 %) 0.145*




11 (4.0 %) 6 (1.4 %) 0.025*
Coronary artery disease 85 (31.3 %) 81 (19.1 %) 0.001*
History of myocardial
infarction
42 (15.4 %) 41 (9.6 %) 0.017*
History of stroke 28 (10.3 %) 15 (3.5 %) <0.001*
Glaucoma 22 (8.1 %) 23 (5.4 %) 0.143*
Hearing problems 50 (18.4 %) 59 (13.9 %) 0.090*
Laboratory results
Haemoglobin (g/dl) 10.9 ± 0.1 11.2 ± 0.2 0.166
Phosphate (mmol/l) 1.8 ± 0.0 1.8 ± 0.0 0.845
Protein (g/l) 66.8 ± 0.6 68.2 ± 0.4 0.058
Cholesterol (mmol/l) 4.6 ± 0.1 4.7 ± 0.1 0.286
C-reactive protein (mg/l) 14.3 ± 1.3 11.1 ± 0.9 0.067
b
Marriage status
Married 157 (59.5 %) 277 (65.5 %) 0.004
Alone 42 (15.9 %) 84 (19.9 %)
Widowed 65 (24.6 %) 62 (14.7 %)
Living conditions
With family 219 (83.3 %) 366 (87.1 %) 0.160*









Elementary 117 (44.0 %) 153 (36.5 %) 0.027
High school 132 (49.6 %) 217 (51.8 %)
College 17 (6.4 %) 49 (11.7 %)
Number of pills taken daily 10.9 ± 0.3 10.6 ± 0.3 0.490
Number of days spent
in hospital during the
last year
24.3 ± 1.8 15.3 ± 1.0 <0.001
Mean values ± SEM
* v2 test
a Self reported by patients
Bold values indicate statistical differences between sub-groups
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Discussion
Based on the results obtained in this study, which
include the largest population of haemodialyzed
patients diagnosed for the presence of depression in
Poland, we can conclude that (a) depressive symptoms
are frequent (38 %) and their presence mainly depends
on time spent in hospitals and (b) presence of central
catheter can be used as a simple marker to identify
patients with higher risk for depression development.
Depressive symptoms rate in studied population is
not different than reported before in many other
studies [3, 13, 15, 30, 31]. We have anticipated that
family-based culture as Polish may have some influ-
ence on depression presence in severely ill patients. It
seems that cultural differences between dialyzed
patients’ populations (European, American, Afro-
American, Taiwan, Japanese) do not affect depression
development, which proves how profound impact on
patients HRQOL, CKD stage 5.
Correlation between presence of depressive symp-
toms and time spent in hospitals during the last year
may be bidirectional. It was already found that
depression in haemodialyzed patients is associated
with the higher rate of hospital admissions [32]. There
are no data if treatment of depression can decrease
hospitalization rate. And we do not know whether
shortening time spent on treatment in hospital will
decrease depression rate in haemodialyzed population.
We assume that time spent in hospitals reflects overall
patient’s health status, seriousness of comorbidities
and need for longer treatment. Causality in these
circumstances is very hard to establish.
The difference in percentage of patients with
depressive symptoms between profit and non-profit
dialysis units requires wider comment. As we under-
stand, there are two explanations of this finding. First
is that the source of the patients of small non-profit
dialysis units (which are in majority right now) is not
large nephrological, emergency and cardiology public
wards. Such sources are mainly outpatients’ clinics.
Second is that their deal with national health provider
does not sufficiently cover expenses on seriously ill
patients who stay longer in hospitals. These two
reasons may create the situation, when in non-profit
dialysis units there are more ill patients with lots of
comorbidities and obviously higher rate of depression
than in public centres. So, the difference in depressive
symptoms rate between profit and non-profit dialysis
units probably results from patients’ allocation and
reflects status of our healthcare system in this area.
Thus, it is established that during the first year after
start of dialysis treatment, there is a higher rate of
depression and suicides in this population [30]. This
time is also characterized by wider usage of central
catheters. Other subpopulation of haemodialyzed
patients are those with problems with vascular access,
with history of many catheters used and with many
vascular changes. Our study did not make a difference
between these two subgroups. All catheter bearers
were identified as a group with significantly higher
BDI score, higher C-reactive protein plasma concen-
tration and more days spent in hospital during the last
year. Such a correlation was not observed in 109
patients investigated by Leinau et al. [33]. Although,
there is connection between presence of a central
catheter and higher possibility of infection and
inflammation, we conclude that higher plasma C-reac-
tive protein level in patients with central catheter
reflects overall worse inflammatory status of these
Table 4 Comparison
between patients dialyzed
with the usage of arterio-















Number of patients 528 (76.1 %) 166 (23.9 %)
Depression (BDI C16) 189 (35.8 %) 75 (45.2 %) 0.029*
BDI score 14.0 ± 0.4 16.7 ± 0.8 0.002
Age (years) 57.9 ± 0.6 63.0 ± 1.1 <0.001
Haemodialysis time (years) 3.8 ± 0.2 2.9 ± 0.4 0.025
Laboratory results
Haemoglobin (g/dl) 11.1 ± 0.2 11.0 ± 0.1 0.682
C-reactive protein (mg/l) 11.0 ± 0.7 15.9 ± 2.0 0.013
Number of days spent in hospital
during the last year
15.6 ± 0.9 28.9 ± 2.4 <0.001
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patients which implicate more intensive treatment in
hospitals.
First episode of depression in general population
mainly occurs below 30 years of age [34] and its
prevalence declines with the age. In our population,
depression was positively correlated with age, and time
of dialysis treatment was not different in groups with or
without depressive symptoms. This is contrary to
previous findings in which depression is mainly bound
to the first 12 months of dialysis treatment with the
higher rate of suicides, especially in younger patients.
This difference could be explained by ‘‘advanced’’
average age of whole investigated population and their
marital status, which can be characterized as ‘‘middle-
aged’’, in majority married (62 %) and living with
family (84 %). That obviously delivers enough social
support. On the other hand, it is understandable that the
longer patients are dialyzed, the higher rate of compli-
cations and comorbidities occurs, with higher possibil-
ity of depression development.
One of the more surprising findings was the same
rate of depression in haemodialyzed man and woman.
It is known that depression is much more frequent
(2 times) in woman than in man all over the world in
different cultures [35]. This is related mainly to higher
stress rate and lower amount of inner resources in
woman. It seems that overall burden connected to
chronic kidney disease and dialysis treatment levels
the stress rate in men and woman, and gender
differences stop to play an important role in depression
development. This could be rather due to rise of stress
level in man than decrease stress in woman in dialysis
population. This is the only speculation, because this
area was not investigated.
Recently, many authors have tried to find a
connection between depression and aggravated
inflammatory status of patients with ESRD [36]. It
was proven that proinflammatory cytokines play an
important role in the pathogenesis of depression in
general population [37, 38]. The same cytokines are
elevated in ESRD patients [39, 40] and may predict
mortality in this group [41]. Also C-reactive protein
(CRP) concentration was used to predict outcome in
haemodialysis patients [42]. Amongst others, inter-
leukin-6 (IL-6) became most often used marker to link
depression and inflammation in patients with CKD,
ESRD and after kidney transplantation [40, 43, 44].
Elevated IL-6 level may increase risk of depres-
sion development in patients with ESRD [45, 46].
Causality of depression and inflammation is unclear,
probably bilateral. It was found that depression is
linked to worse nutritional status of patients with
ESRD [25] that is the part of malnutrition–inflamma-
tion–atherosclerosis (MIA) syndrome. Salawa and
Omima showed in 60 haemodialysis patients the link
between depressive symptoms, poor quality of life and
malnutrition–inflammation complex assessed with
MIA [42]. Additionally, depression is associated with
higher cardiovascular risk in patients with ESRD [26–
28], which also could be mediated through depression-
aggravated atherosclerosis.
Our study has several limitations. We did not include
all patients dialyzed in our region (30 % of all of them
were included). Those who could not or did not want to
participate were not investigated. This certainly under-
estimated the presence of depression as non-compli-
ance is a depression marker, and as inability to fulfil
questionnaire reflects much worse general state of
patient. We did not collected data about work activities
and being on waiting list for transplantation. We may
assume that working patients and those who await
transplantation have better (lower) BDI score. We
chose C-reactive protein as a marker for inflammation
because of its low cost in regard to large studied
population, although as presented recently in many
papers, IL-6 seems to be a better marker. The data
concerning cause of CKD and comorbidities were
obtained from the patients—so credibility of this data
may be questioned. We did not investigated presence of
pain, fatigue and quality of sleep in studied population.
They were proven in other studies to affect depression
rate in haemodialyzed population.
In summary, this study once again proved high
prevalence of depressive symptoms in haemodialyzed
patients. We confirmed a link between depression and
inflammatory status in large group of patients, and we
identified a subpopulation of catheter bearers as a
group with high risk for depression development. The
efforts should be made to shorten inpatients’ treatment
time to decrease occurrence of severe depression. One
of the ways to achieve this is early diagnosis of CKD
and starting dialysis treatment with already ready-to-
puncture arterio-venous fistula. We suggest consider-
ing usage of MIAD syndrome instead of MIA
abbreviation but this idea requires further studies.
Conclusions: 1. Depressive symptoms are fre-
quently found (38.6 %) in haemodialyzed patients in
Upper Silesia part of Poland. 2. Catheter placement
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and inflammation seem to play an important role in the
pathogenesis of depression in haemodialysis patients.
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